Anubha Bajaj*

Consultant, Histopathologist, A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Consultant, Histopathologist, A.B. Diagnostics, India.

Received: November 07, 2022; Published: November 29, 2022

Abstract

Atypical ductal hyperplasia is an intra-ductal, proliferative mammary lesion which emerges as a precursor and demonstrates enhanced probability with frequent metamorphosis into invasive carcinoma breast.

References

1. Tomlinson-Hansen S., et al. “Atypical Ductal Hyperplasia”. Stat Pearls International 2022, Treasure Island, Florida (2022).
2. Bong TSH., et al. “Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision”. Journal of Breast Cancer1 (2022): 37-48.
3. Khoury T. “Pre-neoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions”. Cancers (Basel)3 (2022): 507.
4. Sanders ME and Podoll MB. “Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of De-escalation”. Surgical Pathology Clinics 1 (2022): 95-103.
5. Image 1 Courtesy: Pathology outlines.
6. Image 2 Courtesy: Libre pathology.

Citation

Citation: Anubha Bajaj. “Heteroclite and Preternatural - Atypical Ductal Hyperplasia Breast”. Acta Scientific Cancer Biology 6.7 (2022): 10-13.

Copyright

Copyright: © 2022 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.